836671-02-4

Basic information

• Product Name: 2-Oxazolidinethione, 3-[(2S,3R,4E)-3-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-2-methyl-1-oxo-5- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-4-pentenyl]-4-(phenylmeth yl)-, (4S)-
• CAS NO: 836671-02-4
• Molecular Formula: C28H44BNO5SSi
• Molecular Weight: 545.624
• Mol File: 836671-02-4.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 2-Oxazolidinethione, 3-[(2S,3R,4E)-3-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-2-methyl-1-oxo-5- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-4-pentenyl]-4-(phenylmeth yl)-, (4S)-(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Oxazolidinethione, 3-[(2S,3R,4E)-3-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-2-methyl-1-oxo-5- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-4-pentenyl]-4-(phenylmeth yl)-, (4S)-(836671-02-4)
• EPA Substance Registry System: 2-Oxazolidinethione, 3-[(2S,3R,4E)-3-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-2-methyl-1-oxo-5- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-4-pentenyl]-4-(phenylmeth yl)-, (4S)-(836671-02-4)

Safety Data

• Hazardous Substances Data: 836671-02-4(Hazardous Substances Data)

Upstream product

• 167896-48-2 (E)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)prop-2-en-1-ol 
• 153725-01-0 (2E)-3-(4,4,5,5-tetramethyl-1,2,3-dioxaborolan-2-yl)prop-2-enal 
• 167896-47-1 trimethyl([[(2E)-3-(tetramethyl-1,3,2-dioxaborolan-2-yl)prop-2-en-1-yl]oxy])silane 
• 836671-00-2 1-(4-benzyl-2-thioxooxazolidin-3-yl)-3-hydroxy-2-methyl-5-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-pent-4-en-1-one 
• 18162-48-6 tert-butyldimethylsilyl chloride 

Downstream Products

• 836671-19-3 6,12-dibromo-9-(tert-butyldimethyl-silanyloxy)-2,4,8-trimethyl-15-phenyl-pentadeca-2,4,6,10,12-pentaenoic acid 2-trimethylsilanyl-ethyl ester 
• 836671-18-2 [4-bromo-1-(3,3-dibromo-1-methyl-allyl)-7-phenyl-hepta-2,4-dienyloxy]-tert-butyl-dimethyl-silane 
• 836671-17-1 6-bromo-3-(tert-butyl-dimethyl-silanoxy)-2-methyl-9-phenyl-nona-4,6-dienal 

Relevant articles and documents

Development of an end-game strategy towards apoptolidin: A sequential Suzuki coupling approach

An end-game strategy towards the synthesis of apoptolidin has been demonstrated in a model study, in which the C(1)-C(15) fragment was successfully assembled using three consecutive Suzuki coupling reactions.